In a rat model mimicking early AMD stages, intravitreal injection of human recombinant TGF-β1 prevented retinal insult induced by intravitreal injection of amyloid-beta 1–40 fragments, a constituent of drusen [73,74,75]. Here, TGFB1 is linked to age-related macular degeneration.